PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsdystonia
MeSH D004421 - dystonia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020820:Dyskinesias
$
Success rate
D004421: 
Dystonia
$
Success rate
D014103:Torticollis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmantadine Amantadine  1991-08-23   
CiplaAmantadine Amantadine  2016-09-30   
SandozAmantadine Amantadine  1987-02-18   
Xttrium LaboratoriesAmantadine Amantadine  1998-12-24   
Zydus TherapeuticsAmantadine Amantadine  2016-05-31   
Alembic PharmaceuticalsAmantadine Amantadine  2017-06-21   
Chartwell PharmaceuticalsAmantadine Amantadine  1993-06-28   
Strides Pharma GlobalAmantadine Amantadine  2017-06-09   
BionPharmaAmantadine Amantadine  2008-05-29   
Supernus PharmaceuticalsAmantadine Gocovri 2025-11-23 2017-08-24 $126.811 M Q3/23-Q3/24 
Amantadine Osmolex 2025-11-23 2018-02-16   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
25%
1/4
Phase 3
86%
6/7
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use